In this context, Gal-3 plays a prominent role in the tumour microenvironment, where it is mostly overexpressed, influencing not only cancer growth and progression but also inflammatory processes and oxidative stress, opening up the search for potential inhibitors [8,9,10,11]. The gene discussed is LGALS3; the disease is neoplasm.